Biotechnology | Disease | FDA | Therapeutics
FDA Approves First Drug Shown to Help Patients with Infantile-Onset Niemann-Pick Disease Type C Live Longer
On Nov. 17, 2026, The U.S. Food and Drug Administration approved Lembaz (adrabetadex) injection, the first treatment shown…